Balaji Srinivasan

Balaji Srinivasan
Max Planck Institute for Biology of Ageing | AGE

PhD

About

11
Publications
3,994
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
612
Citations
Citations since 2017
3 Research Items
497 Citations
2017201820192020202120222023020406080100
2017201820192020202120222023020406080100
2017201820192020202120222023020406080100
2017201820192020202120222023020406080100
Additional affiliations
April 2017 - present
Max Planck Institute for Biology of Ageing
Position
  • PostDoc Position
January 2016 - February 2017
Novo Nordisk Foundation Center for Protein Research
Position
  • PostDoc Position
Description
  • Global profiling of the substrates of lysine acetyl-transferases
August 2014 - August 2014
University of Groningen
Position
  • PhD
Description
  • Teaching HPLC methodology for detection and quantification of Coenzyme A and related thiol molecules.
Education
September 2009 - November 2015
University of Groningen
Field of study
  • Coenzyme A biosynthesis
August 2007 - August 2009
University of Groningen
Field of study
  • Top Masters (MSc) in Medical and Pharmaceutical Drug Innovation (MPDI),
June 2002 - June 2006

Publications

Publications (11)
Article
The acetyltransferases CBP and p300 are multifunctional transcriptional co-activators. Here, we combined quantitative proteomics with CBP/p300-specific catalytic inhibitors, bromodomain inhibitor, and gene knockout to reveal a comprehensive map of regulated acetylation sites and their dynamic turnover rates. CBP/p300 acetylates thousands of sites,...
Article
Full-text available
Coenzyme A is an essential metabolite known for its central role in over one hundred cellular metabolic reactions. In cells, Coenzyme A is synthesized de novo in five enzymatic steps with vitamin B5 as the starting metabolite, phosphorylated by pantothenate kinase. Mutations in the pantothenate kinase 2 gene cause a severe form of neurodegeneration...
Article
Full-text available
The metabolic cofactor coenzyme A (CoA) gained renewed attention because of its roles in neurodegeneration, protein acetylation, autophagy and signal transduction. The long-standing dogma is that eukaryotic cells obtain CoA exclusively via the uptake of extracellular precursors, especially vitamin B5, which is intracellularly converted through five...
Patent
Full-text available
The invention relates to (S)-acyl-4'-phosphopantetheine derivatives, methods of their synthesis, and related medical uses of such compounds. Preferred medical uses relate to the treatment of neurodegenerative diseases, such as PKAN.
Article
In all organisms biomolecules play a vital role to enable proper cellular metabolism. Alteration of metabolite homoeostasis disrupts the physiology of cells, leading to various diseases [DeBerardinis and Thompson (2012) Cell, 148, 1132-1144]. Recent studies advances our understanding that some metabolites are not only involved in cellular metabolis...
Article
Full-text available
Pantothenate kinase-associated neurodegeneration (PKAN is a neurodegenerative disease with unresolved pathophysiology. Previously, we observed reduced Coenzyme A levels in a Drosophila model for PKAN. Coenzyme A is required for acetyl-Coenzyme A synthesis and acyl groups from the latter are transferred to lysine residues of proteins, in a reaction...
Article
Full-text available
Pantothenate kinase-associated neurodegeneration (PKAN), a progressive neurodegenerative disorder, is associated with impairment of pantothenate kinase function. Pantothenate kinase is the first enzyme required for de novo synthesis of CoA, an essential metabolic cofactor. The pathophysiology of PKAN is not understood, and there is no cure to halt...

Network

Cited By